Phase II, randomized, placebo-controlled study of dovitinib in combination with fulvestrant in postmenopausal patients with HR+, HER2- breast cancer that had progressed during or after prior endocrine therapy
- Musolino, A.
- Campone, M.
- Neven, P.
- Denduluri, N.
- Barrios, C.H.
- Cortes, J.
- Blackwell, K.
- Soliman, H.
- Kahan, Z.
- Bonnefoi, H.
- Squires, M.
- Zhang, Y.
- Deudon, S.
- Shi, M.M.
- André, F.
ISSN: 1465-542X, 1465-5411
Año de publicación: 2017
Volumen: 19
Número: 1
Tipo: Artículo